Given the body of literature surrounding the role of ACE in coronavirus infections, some have suggested using ACE1 inhibitors, such as enalapril and ramipril, and angiotensin receptor antagonists (ARBs), such as candesartan and valsartan, for COVID-19. The gene discussed is ACE; the disease is COVID-19.